EKF Diagnostics Holdings (LSE:EKF) Total Current Liabilities: £7.42 Mil (As of Dec. 2025)


LSE:EKF EKF Diagnostics Holdings PLC LSE:EKF
50 GF Score
Price £0.25
GF Value £0.28
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is EKF Diagnostics Holdings Total Current Liabilities?

EKF Diagnostics Holdings LSE:EKF -0.78% 50 Total Current Liabilities is £7.42 Mil as of Dec. 2025. GuruFocus rates LSE:EKF with a GF Score™ of 50/100 and a GF Value™ of £0.28 (Fairly Valued). The stock has 4 warning signs investors should review.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. EKF Diagnostics Holdings's total current liabilities for the quarter that ended in Dec. 2025 was £7.42

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

EKF Diagnostics Holdings Total Current Liabilities Related Terms

EKF Diagnostics Holdings Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for EKF Diagnostics Holdings's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EKF Diagnostics Holdings Total Current Liabilities Chart

EKF Diagnostics Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.65 11.74 9.50 6.44 7.42

EKF Diagnostics Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.50 5.38 6.44 6.82 7.42
LSE:EKF
50GF Score
EKF Diagnostics Holdings PLC LSE:EKF
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EKF Diagnostics Holdings Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

EKF Diagnostics Holdings's Total Current Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=3.029+0.398
+Other Current Liabilities+Current Deferred Liabilities
=3.993+0
=7.42

EKF Diagnostics Holdings's Total Current Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=3.029+0.398
+Other Current Liabilities+Current Deferred Liabilities
=3.993+0
=7.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of £7.42 Mil mean?
EKF Diagnostics Holdings (LSE:EKF) has a Total Current Liabilities of £7.42 Mil as of Dec. 2025. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for EKF Diagnostics Holdings and its competitors.
Is EKF Diagnostics Holdings' Total Current Liabilities too high?
EKF Diagnostics Holdings' current Total Current Liabilities is £7.42 Mil. Overall, EKF Diagnostics Holdings has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' Total Current Liabilities compare to ABT and SYK?
EKF Diagnostics Holdings' Total Current Liabilities of £7.42 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Medical Devices & Instruments company?
A good Total Current Liabilities depends on the Medical Devices & Instruments industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for EKF Diagnostics Holdings and its competitors. EKF Diagnostics Holdings's current Total Current Liabilities is £7.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Fairly Valued. The stock's GF Value™ is £0.28, compared to a current price of £0.25 — trading 9.3% below its estimated fair value. The current Total Current Liabilities is £7.42 Mil. EKF Diagnostics Holdings' overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current Total Current Liabilities is £7.42 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?

Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued. The current stock price of £0.25 is trading 9.3% below its estimated GF Value™ of £0.28. GuruFocus considers EKF Diagnostics Holdings to be Fairly Valued.

Key valuation signals for LSE:EKF:

  • Total Current Liabilities: £7.42 Mil
  • GF Value™: £0.28 vs. price of £0.25 (9.3% below fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EKF Diagnostics Holdings Business Description

Other Exchanges EKDHF:USALYF:Germany
Address 19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
50GF Score

Get the complete analysis for LSE:EKF

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.25
Price
£0.28
GF Value